Singapore
GlaxoSmithKline opened its new $13-million (US) medicinal chemistry laboratory in Singapore in March 2007. The facility is located in the biomedical research hub Biopolis and is part of GSK’s existing Centre for Research in Cognitive and Neurodegenerative Disorders. The laboratory will enable researchers to engage in collaborative biology and chemistry pre-clinical research.
